Lantern Pharma Inc Strategic Asset Allocation Index
Lantern Pharma Inc strategic asset allocation index. Lantern Pharma Inc (LTRN) has a Strategic Asset Allocation Index of 0.1% as of June 2023. Strategic assets (PP&E of $49.95K plus long-term investments of $-) total $49.95K, measured against net assets of $48.26 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Lantern Pharma Inc (LTRN) net asset quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Lantern Pharma Inc (2019–2022)
Strategic asset allocation index of Lantern Pharma Inc from 2019 to 2022. This chart shows how Lantern Pharma Inc's Strategic Asset Allocation Index has evolved across 4 annual periods from 2019 to 2022. As of June 2023, the index stands at 0.1%, representing strategic assets of $49.95K against net assets of $48.26 Million USD. Check Lantern Pharma Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
Lantern Pharma Inc Strategic Asset Allocation Index by Year (2019–2022)
Lantern Pharma Inc strategic asset allocation index by year from 2019 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Lantern Pharma Inc from 2019 to 2022, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Lantern Pharma Inc (LTRN) total market value.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.1% | $48.01K | $48.01K | $- | $56.04 Million | ▼ -0.2 pp |
| 2021 | 0.3% | $216.19K | $216.19K | $- | $71.57 Million | ▲ +0.2 pp |
| 2020 | 0.1% | $21.51K | $21.51K | $- | $19.70 Million | ▼ -0.8 pp |
| 2019 | 0.9% | $8.76K | $8.76K | $- | $943.28K | — |